Literature DB >> 11049776

Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study.

L Ostergaard1, B Andersen, J K Møller, F Olesen.   

Abstract

We compared the efficacy of a screening program for urogenital Chlamydia trachomatis infections based on home sampling with that of a screening program based on conventional swab sampling performed at a physician's office. Female subjects, comprising students at 17 high schools in the county of Aarhus, Denmark, were divided into a study group (tested by home sampling) and a control group (tested in a physician's office). We assessed the number of new infections and the number of subjects who reported being treated for pelvic inflammatory disease (PID) at 1 year of follow-up; 443 (51.1%) of 867 women in the intervention group and 487 (58.5%) of 833 women in the control group were available for follow-up. Thirteen (2.9%) and 32 (6.6%) new infections were identified in the intervention group and the control group, respectively (Wilcoxon exact value, P=.026). Nine (2.1%) women in the intervention group and 20 (4.2%) in the control group reported being treated for PID (P=.045), indicating that a screening strategy involving home sampling is associated with a lower prevalence of C. trachomatis and a lower proportion of reported cases of PID.

Entities:  

Mesh:

Year:  2000        PMID: 11049776     DOI: 10.1086/318139

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  45 in total

1.  Current Issues in Screening for Chlamydia trachomatis.

Authors:  Robert L. Cook; Lars ØStergaard
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.725

Review 2.  Beyond "safe sex"--can we fight adolescent pelvic inflammatory disease?

Authors:  Bahaa Abu Raya; Ellen Bamberger; Nogah C Kerem; Aharon Kessel; Isaac Srugo
Journal:  Eur J Pediatr       Date:  2012-07-10       Impact factor: 3.183

3.  Evaluating novel interventions for chlamydia screening.

Authors:  N Low
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

4.  Home compared with clinic-based screening for sexually transmitted infections: a randomized controlled trial.

Authors:  Anna S Graseck; Gina M Secura; Jenifer E Allsworth; Tessa Madden; Jeffrey F Peipert
Journal:  Obstet Gynecol       Date:  2010-12       Impact factor: 7.661

5.  Discordance between trends in chlamydia notifications and hospital admission rates for chlamydia related diseases in New South Wales, Australia.

Authors:  M Y Chen; C K Fairley; B Donovan
Journal:  Sex Transm Infect       Date:  2005-08       Impact factor: 3.519

6.  Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study.

Authors:  N Low; M Egger; J A C Sterne; R M Harbord; F Ibrahim; B Lindblom; B Herrmann
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

Review 7.  Screening for genital chlamydia infection.

Authors:  Nicola Low; Shelagh Redmond; Anneli Uusküla; Jan van Bergen; Helen Ward; Berit Andersen; Hannelore Götz
Journal:  Cochrane Database Syst Rev       Date:  2016-09-13

8.  Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: implications of first results for the analysis.

Authors:  Ingrid V F van den Broek; Christian J P A Hoebe; Jan E A M van Bergen; Elfi E H G Brouwers; Eva M de Feijter; Johannes S A Fennema; Hannelore M Götz; Rik H Koekenbier; Sander M van Ravesteijn; Eline L M Op de Coul
Journal:  BMC Infect Dis       Date:  2010-04-07       Impact factor: 3.090

9.  Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial.

Authors:  Pippa Oakeshott; Sally Kerry; Adamma Aghaizu; Helen Atherton; Sima Hay; David Taylor-Robinson; Ian Simms; Phillip Hay
Journal:  BMJ       Date:  2010-04-08

10.  Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial.

Authors:  Pippa Oakeshott; Sally Kerry; Helen Atherton; Adamma Aghaizu; Sima Hay; David Taylor-Robinson; Ian Simms; Phillip Hay
Journal:  Trials       Date:  2008-12-10       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.